The effects of gender-affirming hormone therapy on myocardial, hepatic, pancreatic lipid content, body fat distribution and other cardiometabolic risk factors: A magnetic resonance-based study in transgender individuals
6 months of GAHT were not associated with statistically significant changes in myocardial, hepatic, or pancreatic lipid content. Short-term GAHT led to a marked body fat redistribution with a significant decrease in the VAT/SAT ratio in TW.
Authors
- Siegfried Trattnig (ORCID: https://orcid.org/0000-0003-1623-3303)
- Martin Krššák (ORCID: https://orcid.org/0000-0001-9717-803X)
- Dorota Sluková (ORCID: https://orcid.org/0009-0009-5521-1124)
- Jürgen Harreiter (ORCID: https://orcid.org/0000-0003-2508-9403)
- Ivica Just
- Alexandra Kautzky‐Willer (ORCID: https://orcid.org/0000-0002-3520-4105)
- Carola Deischinger (ORCID: https://orcid.org/0000-0003-4857-222X)
- Lana Kosi‐Trebotic (ORCID: https://orcid.org/0000-0001-6201-2056)
- Ulrike Kaufmann (ORCID: https://orcid.org/0000-0003-4317-5794)
Institutions
- Vienna General Hospital (AT)
- Salzburger Landeskliniken (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Journal of Clinical & Translational Endocrinology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1016/j.jcte.2024.100379
- Citations
- 3
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 1.93